Industry Supported Session
IL-23 Inhibitors in IBD: Incorporating New Evidence and Updated Guidelines into Clinical Practice
45 min
Saturday, June 13, 2026
10:30 AM - 11:15 AM
Supported by an educational grant from Johnson & Johnson.
-
Speaker
-
David Schwartz MD, FACG
-